References
- Hainsworth J. D., Wolff S. N., Stein R. S., Greer J. P., Cousar J. B., Greco F. A. Effects of mega. COMLA (cyclophosphamide, cytarabine, vincristine, and methotrexate followed by leucovorin and prednisone) in the treatment of lymphoid neoplasms with very poor prognosis. Cancer Treat. Rep. 1986; 70: 953–958
- McMaster M. L., Greer J. P., Wolff S. N., et al. Results of treatment with high intensity brief duration chemotherapy in poor prognostic non-Hodgkin's lymphoma. Cancer 1991; 68: 233–241
- McMaster M L., Greer J. P., Greco F A., Johnson D. H., Wolffs N., Hainsworth J. D. Effective treatment of small-noncleaved lymphoma with high intensity, brief duration chemotherapy. J. Clin. Oncol 1991; 9: 941–946
- Kaplan E. L., Meier P. Nonparametric estimation from incomplete observations. J. Am. Stat. Assoc 1958; 53: 457–481
- Shipp M. A., Harrington D. P., Klatt M. M., et al. Identification of major prognostic subgroups of patients with large cell lymphoma treated with m-BACOD or M-BACOD. Ann. Intern. Med 1986; 104: 757–765
- Fisher R. I., Gaynor E., Dahlberg S., et al. A phase III comparison of CHOP vs. m-BACOD vs. ProMACE-CytaBOM vs. MACOP-B in patients with intermediate or high grade non-Hodgkin's lymphoma: preliminary results of SWOG-8516 (Intergroup 0067), the national high priority lymphoma study. Proc Am. Soc Clin. Oncol 1992; 11: 315
- Kümo P., Conners J. M. MACOP-B chemotherapy for the treatment of diffuse large cell lymphoma. Ann. Intern. Med 1985; 102: 596–602
- Oster W., Forsthuber T., Hennekeuser H. H., et al. MACOP-B chemotherapy for the treatment of high grade and intermediate grade non-Hodgkin's lymphoma. Blut 1990; 60: 23–27
- Boyd D. B., Coleman M., Papish S. W., et al. COP-BLAM HI: infusional combination chemotherapy for diffuse large-cell lymphoma. J. Clin. Oncol 1988; 6: 425–433
- Longo D. L., DeVita V. T., Jr., Duffey P. L., et al. Superiority of ProMACE-CytaBom over ProMACE-MOPP in the treatment of advanced diffuse aggressive lymphoma: Results of a prospective randomized trial. J. Clin. Oncol 1991; 9: 25–38
- Hryniuk W. M. The importance of dose intensity in the outcome of chemotherapy. Important Advances in Oncology, V. T. DeVita, Jr., S. Hellman, S. A. Rosenberg. JB Lippincott, Philadelphia 1988; 121–143
- Coiffier B., Grisselbrecht C., Herbrecht R., Tilly H., Bosly A., Brousse N. LNH-84 regimen: A multicenter study of intensive chemotherapy in 737 patients with aggressive malignant lymphoma. J. Clin. Oncol 1989; 7: 1018–1026
- Coleman C. N., Cohen J. R., Burke J. S., Rosenberg S. A. Lymphoblastic lymphoma in adults: Results of a pilot protocol. Blood 1981; 57: 679–684
- Levine A. M., Forman S. J., Meyer P. R., et al. Successful therapy of convoluted T-lymphoblastic lymphoma in the adult. Blood 1983; 61: 92–98
- Magrath I. T., Janus C., Edwards B. K., et al. An effective therapy for both undifferentiated (including Burk-itt's) lymphomas and lymphoblastic lymphomas in children and young adults. Blood 1984; 63: 1102–1111
- Sullivan M. P., Ramirez I. Curability of Burkitt's lymphoma with high-dose cyclophosphamide high-dose methotrexate therapy and intrathecal chemoprophylaxis. J. Clin. Oncol. 1985; 3: 627–636
- Murphy S. B., Bowman W. P., Abromowitch M., et al. Results of treatment of advanced-stage Burkitt's lymphoma and B cell acute lymphoblastic leukemia with high-dose fractionated cyclophosphamide and coordinated high-dose methotrexate and cytarabine. J. Clin. Oncol. 1986; 4: 1732–1739
- Hutchinson R. E., Murphy S. B., Fairclough D. Z., et al. Diffuse small noncleaved cell lymphoma in children, Burkitt's versus non-Burkitt's types: Results from the Pediatrie Oncology Group and St. Jude's Research Hospital. Cancer 1989; 64: 23–28
- Armitage J. O. Bone marrow transplantation in the treatment of patients with lymphoma. Blood 1989; 73: 1749–1758
- Oviatt D. L., Cousar J. B., Flexner J. M., et al. Malignant lymphoma of follicular center cell again in humans: IV. Small transformed (non-cleaved) cell lymphoma of the non-Burkitt's type. Cancer 1983; 52: 1196–1201
- Levine A. M., Pavlova Z., Pockros A. W., et al. Small noncleaved follicular center cell lymphoma: Burkitt and non-Burkitt variants in the United States: I. clinical features. Cancer 1983; 52: 1073–1079
- Connors J. M., Klimo P. MACOP-B chemotherapy for malignant lymphomas and related conditions: 1987 update and additional observations. Semin. Hematol. 1988; 25(Suppl 2)41–46